Revance Therapeutics Inc (NASDAQ:RVNC)

13.53
Delayed Data
As of 3:59pm ET
 -0.48 / -3.43%
Today’s Change
13.01
Today|||52-Week Range
33.83
-52.26%
Year-to-Date

Today’s Trading

Previous close14.01
Today’s open13.96
Day’s range13.35 - 13.97
Volume36,753
Average volume (3 months)836,831
Market cap$1.1B
Data as of 3:59pm ET, 10/27/2021

Growth & Valuation

Earnings growth (last year)-32.56%
Earnings growth (this year)+12.04%
Earnings growth (next 5 years)+192.00%
Revenue growth (last year)+3,610.65%
P/E ratioNM
Price/Sales107.27
Price/Book2.85

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...-0.15-0.83%
----
ENDPEndo International P...-0.17-3.89%
ACRSAclaris Therapeutics...+0.08+0.50%
Data as of 4:47pm ET, 10/27/2021

Financials

Next reporting dateNovember 4, 2021
EPS forecast (this quarter)-$0.97
Annual revenue (last year)$15.3M
Annual profit (last year)-$282.1M
Net profit margin-1,840.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts